Bisoprolol in chronic heart failure

被引:1
作者
Davis, M [1 ]
机构
[1] Moorfield House Surg, Garforth LS25 1AN, Leeds, England
来源
HOSPITAL MEDICINE | 2000年 / 61卷 / 02期
关键词
D O I
10.12968/hosp.2000.61.2.1277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The evidence for the use of beta-blockers in heart failure is substantial. Latest recommendations and guidelines suggest that retest heart failure patients should be on a drug regimen of an angiotensin-converting enzyme inhibitor diuretic and a beta-blocker. However, despite the evidence front trials, the majority of patient are not yet treated appropriately, with only 5% receiving a beta-blocker.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 9 条
[1]   BISOPROLOL IN ANGINA-PECTORIS [J].
BETHGE, H ;
LEOPOLD, G ;
WAGNER, G .
CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (02) :110-122
[2]  
Hjalmarson Å, 1999, LANCET, V353, P2001
[3]  
Hobbs FDR, 1999, HEART, V82, P8
[4]  
Lechat P, 1999, LANCET, V353, P9
[5]   A RANDOMIZED TRIAL OF BETA-BLOCKADE IN HEART-FAILURE - THE CARDIAC-INSUFFICIENCY BISOPROLOL STUDY (CIBIS) [J].
LECHAT, P ;
JAILLON, P ;
FONTAINE, ML ;
CHANTON, E ;
MESENGE, C ;
GAGEY, S ;
GUILLARDEAU, A ;
DUSSOUS, V .
CIRCULATION, 1994, 90 (04) :1765-1773
[6]  
Malek M, 1999, HEART, V82, P11
[7]  
MCMURRAY JV, 1999, 21 C EUR SOC CARD BA
[8]   The effect of carvedilol on morbidity and mortality in patients with chronic heart failure [J].
Packer, M ;
Bristow, MR ;
Cohn, JN ;
Colucci, WS ;
Fowler, MB ;
Gilbert, EM ;
Shusterman, NH .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1349-1355
[9]  
WELLSTEIN A, 1987, European Heart Journal, V8, P3